Back

Screen-detected atrial fibrillation prevalence and adherence to therapeutic recommendations in a fully digital nationwide patch-based ECG screening: the NORSCREEN randomised clinical trial

30 August 2026 (09:27 - 09:45)
Organised by: Logo
Congress Presentation Part of: Predicting atrial fibrillation: promise, limitations, or screening Prevalence and Incidence of Atrial Fibrillation ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Sigrun Halvorsen

Oslo University Hospital Ulleval, Oslo (Norway)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on predicting atrial fibrillation: promise, limitations, or screening
Professor R. Schnabel (Hamburg, DE)
Slides Video
Presentation thumbnail
Anthropometric and lifestyle indicators of incident atrial fibrillation in a large, population-based Swedish population
Doctor S. Cederstrom (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Potassium uptitration and risk of atrial fibrillation - a prespecified analysis of the POTCAST randomised clinical trial
Doctor C. Zheng (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
AI-derived LA volume index, LA/RA and LA/LV volume ratios from coronary artery calcium scans predict long-term atrial fibrillation and stroke
Doctor A. Azimi (Calgary, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Predicting atrial fibrillation: promise, limitations, or screening
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 09:27 CET
You may be interested in
thumbnail
Congress Presentation
Fully digital enrollment in the NORwegian atrial fibrillation self-SCREENing trial (NORSCREEN)
30 August 2025
thumbnail
Congress Presentation
Atrial fibrillation screening: is it worthwhile and does it influence atrial fibrillation management across the life span?
1 September 2024
thumbnail
Congress Presentation
Reliability of continuous single-lead patch ECG interpretation for atrial fibrillation detection: Insights from the NORSCREEN trial.
30 August 2025
thumbnail
Congress Presentation
FIND-AF: Machine learning guided atrial fibrillation screening
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources